The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
WCLC 2023 | Current state and future goals in lung cancer screening
David Yankelevitz, MD, Mount Sinai School of Medicine, New York, NY, discusses the current state and future goals for lung cancer screening. The number of measurements and findings generated during screenings has improved significantly but the reporting of additional findings such as emphysema remains controversial. Dr Yankelevitz proposes that the field decides which additional findings should be prioritised and how these discoveries can be communicated to patients effectively. This interview took place at the 2023 World Conference on Lung Cancer (WCLC) in Singapore, Singapore.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
